Interpace Biosciences Files Q1 2025 10-Q
Ticker: IDXG · Form: 10-Q · Filed: May 8, 2025 · CIK: 1054102
| Field | Detail |
|---|---|
| Company | Interpace Biosciences, Inc. (IDXG) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, equity
TL;DR
INTERPACE BIOSCIENCES FILES Q1 2025 10-Q - FINANCIALS SHOWING CHANGES IN EQUITY ACCOUNTS.
AI Summary
Interpace Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including balance sheet data for common stock, treasury stock, and additional paid-in capital as of December 31, 2023, and March 31, 2025. It also provides comparative data for the first quarter of 2024 and 2025.
Why It Matters
This filing provides investors with an update on Interpace Biosciences' financial position and performance for the first quarter of 2025, crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new risks disclosed.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of 2025 financial data)
- Q1 2024 — Comparative Period (First quarter of 2024 financial data for comparison)
Key Players & Entities
- INTERPACE BIOSCIENCES, INC. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250508 (date) — Filing Date
- 0001054102 (company) — Central Index Key
FAQ
What were the key changes in Interpace Biosciences' equity accounts between December 31, 2023, and March 31, 2025?
The filing provides data for common stock, treasury stock, and additional paid-in capital for both dates, indicating changes in these accounts over the period.
What is the fiscal year end for Interpace Biosciences?
The fiscal year end for Interpace Biosciences is December 31.
What is the SIC code for Interpace Biosciences?
The Standard Industrial Classification (SIC) code for Interpace Biosciences is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
When was Interpace Biosciences formerly known as Interpace Diagnostics Group, Inc.?
The company changed its name from Interpace Diagnostics Group, Inc. on December 23, 2015.
What is the business address of Interpace Biosciences?
The business address is Waterview Plaza, Suite 310, 2001 Route 46, Parsippany, NJ 07054.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding INTERPACE BIOSCIENCES, INC. (IDXG).